Tivic Health Systems, Inc. (TIVC)

Market Cap	3.69M
Revenue (ttm)	516,000
Net Income (ttm)	-5.68M
Shares Out	878.34K
EPS (ttm)	-13.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,679
Open	4.120
Previous Close	4.120
Day's Range	4.111 - 4.300
52-Week Range	2.430 - 16.077
Beta	2.04
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2025

About TIVC

Tivic Health Systems, Inc. operates as a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus pain, pressure, and congestion. The company sells its products on online retailers, commercial distributors, and through its own websites; The company’s lead product include Entolimod, a biologic program focuses on immunotherapeutics is the late-stage TLR5 agonist for the treatment of acute radiation syndrome. In addition, it markets commercial produ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: TIVC
• Website: https://tivichealth.com

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.